Survivals in the whole cohort and in subgroups according to the use of HDC-ASCT after ICE. OS (A,C) and PFS (B) in the whole cohort (A-B) and in patients who received HDC-ASCT (blue line) or not (red line) after ICE (C). OS in patients in CR/PR (D), in CR (E), or in PR (F) after ICE who received HDC-ASCT (blue line) or not (red line).